Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

CELZ-201-DDT is a regenerative stem cell-based therapy being developed as a potential treatment for chronic low back pain associated with degenerative disc disease.

HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective strategy for increasing colorectal cancer screening rates, according to a study published online August 4 ...

"If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." ...

HealthDay News — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing.

HealthDay News — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.